IRCSX
Price
$12.06
Change
-$0.12 (-0.99%)
Updated
Nov 13 closing price
TAISX
Price
$10.82
Change
-$0.09 (-0.82%)
Updated
Nov 13 closing price
Ad is loading...

IRCSX vs TAISX

Header iconIRCSX vs TAISX Comparison
Open Charts IRCSX vs TAISXBanner chart's image
Bernstein International Small Cap SCB
Price$12.06
Change-$0.12 (-0.99%)
VolumeN/A
CapitalizationN/A
Nuveen Quant Intl Small Cap Eq I
Price$10.82
Change-$0.09 (-0.82%)
VolumeN/A
CapitalizationN/A
IRCSX vs TAISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IRCSX vs. TAISX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRCSX is a Buy and TAISX is a Buy.

FUNDAMENTALS
Fundamentals
TAISX has more cash in the bank: 1.23B vs. IRCSX (1.08B). TAISX pays higher dividends than IRCSX: TAISX (2.81) vs IRCSX (2.58). IRCSX was incepted earlier than TAISX: IRCSX (9 years) vs TAISX (8 years). TAISX is a more actively managed with annual turnover of: 114.00 vs. IRCSX (50.00). IRCSX has a lower initial minimum investment than TAISX: IRCSX (5000) vs TAISX (100000). IRCSX annual gain was more profitable for investors over the last year : 20.96 vs. TAISX (18.82). IRCSX return over 5 years is better than : 21.56 vs. TAISX (19.55).
IRCSXTAISXIRCSX / TAISX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years8 years-
Gain YTD9.2386.128151%
Front LoadN/AN/A-
Min. Initial Investment50001000005%
Min. Initial Investment IRAN/AN/A-
Net Assets1.08B1.23B88%
Annual Yield % from dividends2.582.8192%
Returns for 1 year20.9618.82111%
Returns for 3 years-6.96-6.35110%
Returns for 5 years21.5619.55110%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OFS8.02-0.03
-0.37%
OFS Capital Corp
TECH74.40-0.29
-0.39%
Bio-Techne Corp
LUNR10.40-0.60
-5.45%
Intuitive Machines
PTGX43.19-3.31
-7.12%
Protagonist Therapeutics
ONVO0.36-0.04
-9.42%
Organovo Holdings